<DOC>
	<DOCNO>NCT02315170</DOCNO>
	<brief_summary>To determine novel intraocular injection guide ( IIG ) reduce patient discomfort intravitreal injection .</brief_summary>
	<brief_title>Assessment Novel Intraocular Injection Guide</brief_title>
	<detailed_description>This study conduct assess potential intraocular injection guide increase comfort level injection . The hypothesis patient feel increase comfort device eliminates need speculum still keep eyelid apart , allow physician deliver treatment . The result study allow physician select optimal device patient comfort well-being intravitreal injection</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<criteria>Subjects must receive bilateral injection dose vascular endothelial growth factor ( VEGF ) inhibitor Injections eye must give day Male female age 18 year old Any condition reason precludes subject 's ability comply study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>diabetic retinopathy</keyword>
	<keyword>age-related macular edema</keyword>
</DOC>